Cargando…

Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies

BACKGROUND: Brincidofovir (BCV) is an orally bioavailable lipid conjugate of cidofovir (CDV) with increased in vitro potency relative to CDV against all 5 families of double-stranded DNA viruses that cause human disease. After intravenous (IV) administration of CDV, the organic anion transporter 1 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tippin, Timothy K., Morrison, Marion E., Brundage, Thomas M., Momméja-Marin, Hervé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Therapeutic Drug Monitoring 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113238/ https://www.ncbi.nlm.nih.gov/pubmed/27851688 http://dx.doi.org/10.1097/FTD.0000000000000353

Ejemplares similares

Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis
por: Lanier, E. Randall, et al.
Publicado: (2016)

Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
por: Wire, Mary Beth, et al.
Publicado: (2017)

1421. IV Brincidofovir (BCV): Pharmacokinetics (PK) and Safety of Multiple Ascending Doses (MAD) in Healthy Subjects
por: Naderer, Odin, et al.
Publicado: (2018)

Experimental Treatment of Ebola Virus Disease with Brincidofovir
por: Dunning, Jake, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
por: Marty, Francisco M., et al.
Publicado: (2018)

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak
por: Foster, Scott A., et al.
Publicado: (2017)

Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity
por: Hagos, Yohannes, et al.
Publicado: (2010)

Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection
por: Chan, Shuk Ying, et al.
Publicado: (2021)

Explanation and inference: mechanistic and functional explanations guide property generalization
por: Lombrozo, Tania, et al.
Publicado: (2014)

Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
por: Sudhindra, Praveen, et al.
Publicado: (2019)

Pseudo‐mechanistic Explanations in Psychology and Cognitive Neuroscience
por: Hommel, Bernhard
Publicado: (2019)

Limitations of Mechanistic Model of Explanation in Biological Psychiatry
por: Salcedo Gómez, M., et al.
Publicado: (2022)

Clarifying the relation between mechanistic explanations and reductionism
por: Couch, Mark
Publicado: (2023)

Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
por: Huo, Xiaokui, et al.
Publicado: (2019)

Uniporter substrate binding and transport: reformulating mechanistic questions
por: Zhang, Xuejun C., et al.
Publicado: (2016)

Substrate transport and anion permeation proceed through distinct pathways in glutamate transporters
por: Cheng, Mary Hongying, et al.
Publicado: (2017)

Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation
por: Van Genechten, T., et al.
Publicado: (2020)

Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro
por: Guo, Shibang, et al.
Publicado: (2023)

The next step: mirror neurons, music, and mechanistic explanation
por: Matyja, Jakub R.
Publicado: (2015)

Mechanistic Explanation of the Weak Carbonic Anhydrase’s Esterase Activity
por: Piazzetta, Paolo, et al.
Publicado: (2017)

A mechanistic explanation of the transition to simple multicellularity in fungi
por: Heaton, Luke L. M., et al.
Publicado: (2020)

Context-sensitive computational mechanistic explanation in cognitive neuroscience
por: de Wit, Matthieu M., et al.
Publicado: (2022)

An Explanation
por: Morrison, R. T., et al.
Publicado: (1889)

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
por: Vial, Romain, et al.
Publicado: (2017)

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
por: Hutson, Christina L., et al.
Publicado: (2021)

A Mechanistic Explanation for the Regioselectivity of Nonenzymatic RNA Primer Extension
por: Giurgiu, Constantin, et al.
Publicado: (2017)

Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir
por: Hanaoka, Nozomu, et al.
Publicado: (2022)

Mechanistic and topological explanations in medicine: the case of medical genetics and network medicine
por: Darrason, Marie
Publicado: (2015)

Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects
por: Imran, Mohd., et al.
Publicado: (2023)

Bambusurils as a mechanistic tool for probing anion effects
por: Jašíková, Lucie, et al.
Publicado: (2019)

Mechanistic Explanations for Restricted Evolutionary Paths That Emerge from Gene Regulatory Networks
por: Cotterell, James, et al.
Publicado: (2013)

A “Mechanistic” Explanation of the Multiple Helical Forms Adopted by Bacterial Flagellar Filaments
por: Calladine, C.R., et al.
Publicado: (2013)

Cadmium Transporters in the Kidney and Cadmium-Induced Nephrotoxicity
por: Yang, Hong, et al.
Publicado: (2015)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions
por: Li, R, et al.
Publicado: (2015)

Glial and Neuronal Glutamate Transporters Differ in the Na(+) Requirements for Activation of the Substrate-Independent Anion Conductance
por: Divito, Christopher B., et al.
Publicado: (2017)

Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
por: Louisse, Jochem, et al.
Publicado: (2022)

Tetrapodal Anion Transporters †
por: Gilchrist, Alexander M., et al.
Publicado: (2020)

Dental Trade Association: An Explanation
por: Morrison, R. T., et al.
Publicado: (1889)

Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
por: McKeage, M. J., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_kfu7u4dqfm07i8g4fa168skdef